中國放寬防疫措施後 國內航班量急速回升
自中國放寬部分防疫措施後,中國航空業界正加快增加國內航班。據航空分析公司Cirium數據,12月12日國內航班總數與11月28日相比急增1.58倍至7,290班。
東方航空(00670.HK)周三表示,航班量急速增加,相比12月1日的543班次,國內航班增長超過150%;運輸旅客近14萬人次,較月初增長近1.4倍。南方航空(01055.HK)表示,由於防疫規定出現調整,公司正增加新航班。春秋航空則稱,最近機票搜尋量是上年同期的逾兩倍。
國泰(00293.HK)稱,今年第四季增加約3,000班新航班,但預計要到2024年才能完全恢復到疫情前的運力水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.